| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Simon Ostergaard Ph.D. CEO | OTC PINK Exchange | - ISIN |
| Sweden Country | 231 Employees | - Last Dividend | - Last Split | - IPO Date |
CellaVision AB (publ) is at the forefront of digitalizing hematological analyses by offering innovative instruments, software, and reagents for blood and body fluids analysis. Operating both in Sweden and internationally, the company is committed to simplifying and automating the process of performing blood and body fluid differentials. Since its foundation in 1994, CellaVision has been centering its developments around easing the workload in laboratories, aiming at enhancing accuracy, efficiency, and connectivity across hematology labs worldwide. Headquartered in Lund, Sweden, CellaVision continues to evolve, focusing on solutions that support laboratories in speeding up the review process while maintaining high-quality diagnostic standards.
CellaVision's product lineup is designed to automate, standardize, and simplify the examination of blood and body fluids, which is critical in diagnosing various diseases. The following is a breakdown of their main products and services: